Corpus Intelligence IC Memo — EVEREST REHABILITATION HOSPITAL NORT 2026-04-26 14:13 UTC
IC Memo — EVEREST REHABILITATION HOSPITAL NORT
Investment Committee Memorandum | OH | 36 beds | Grade D | EBITDA uplift $216K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

EVEREST REHABILITATION HOSPITAL NORT

CCN 363045 | BUTLER, OH | 36 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

EVEREST REHABILITATION HOSPITAL NORT is a 36-bed rural/critical access in BUTLER, OH with $2.7M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 58.9% Medicare, 1.1% Medicaid, and 40.0% commercial.

Thesis: Turnaround. Our ML models identify $216K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -131.1% (+789bps).

Net Revenue HCRIS$2.7M
Current EBITDA COMPUTED$-3.8M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS26.0%
Revenue / Bed COMPUTED$76K
Net-to-Gross HCRIS47.2%
Distress Probability ML57.6%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
104
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -100.0% places it below the state median. Among 104 size-comparable peers (18-72 beds), the median margin is -1.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-72), prioritizing same-state peers. 104 hospitals in the comp set.

HospitalStateBedsRevenueMargin
EVEREST REHABILITATION HOSPITA (Target)OH36$2.7M-100.0%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $216K (789bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$61K+223bp12mo
Net Collection Rate93.5%97.0%$58K+210bp18mo
Cost to Collect4.5%2.5%$55K+200bp12mo
A/R Days Reduction5200.0%3800.0%$33K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+35bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$61K
Net Collection Rate
$58K
Cost to Collect
$55K
A/R Days Reduction
$33K
Clean Claim Rate
$10K
Total EBITDA Uplift$216K
Current EBITDA$-3.8M
+ RCM Uplift+$216K
Pro Forma EBITDA$-3.6M
Current Margin-100.0%
Pro Forma Margin-131.1%
WC Released (1x)$105K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.9M$-23.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.9M$-27.2M0.00x-100.0%
Bull Case9.0x11.0x$-5.3M$-28.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.3M$-32.5M0.00x-100.0%
Bear Case11.0x10.0x$-6.4M$-22.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.4M$-26.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 58.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 26.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 104 hospitals with 18-72 beds
  • Same-state prioritization (n=105)
  • Comp margins: P25=-11.1% / P50=-1.7% / P75=12.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.